These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus. Bertolaccini ML, Atsumi T, Escudero Contreras A, Khamashta MA, Hughes GR. J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209 [Abstract] [Full Text] [Related]
3. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests. Day HM, Thiagarajan P, Ahn C, Reveille JD, Tinker KF, Arnett FC. J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167 [Abstract] [Full Text] [Related]
4. High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome. Fanopoulos D, Teodorescu MR, Varga J, Teodorescu M. J Rheumatol; 1998 Apr; 25(4):675-80. PubMed ID: 9558168 [Abstract] [Full Text] [Related]
5. Anti-beta2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus. Danowski A, Kickler TS, Petri M. J Rheumatol; 2006 Sep; 33(9):1775-9. PubMed ID: 16960938 [Abstract] [Full Text] [Related]
14. Antibodies to high-density lipoprotein and beta2-glycoprotein I are inversely correlated with paraoxonase activity in systemic lupus erythematosus and primary antiphospholipid syndrome. Delgado Alves J, Ames PR, Donohue S, Stanyer L, Nourooz-Zadeh J, Ravirajan C, Isenberg DA. Arthritis Rheum; 2002 Oct; 46(10):2686-94. PubMed ID: 12384928 [Abstract] [Full Text] [Related]
15. [Antibodies to beta2-glycoprotein I in systemic lupus erythematosus: new laboratory marker of antiphospholipid syndrome]. Reshetniak TM, Derksen RV, Alekberova ZS, Horbach D, De Groot F, Nasonov EL, Kalashnikova LA, Match ES, Nasonova VA. Klin Med (Mosk); 1998 Oct; 76(3):36-40. PubMed ID: 9575746 [Abstract] [Full Text] [Related]
16. [Antiphospholipid syndrome and stroke]. Kitagawa Y. Rinsho Shinkeigaku; 2005 Nov; 45(11):852-5. PubMed ID: 16447744 [Abstract] [Full Text] [Related]
17. Anti-beta2-glycoprotein I antibodies in pediatric systemic lupus erythematosus and antiphospholipid syndrome. von Scheven E, Glidden DV, Elder ME. Arthritis Rheum; 2002 Aug; 47(4):414-20. PubMed ID: 12209489 [Abstract] [Full Text] [Related]
18. High avidity anti-beta 2-glycoprotein I antibodies in patients with antiphospholipid syndrome. Cucnik S, Kveder T, Krizaj I, Rozman B, Bozic B. Ann Rheum Dis; 2004 Nov; 63(11):1478-82. PubMed ID: 15479898 [Abstract] [Full Text] [Related]
19. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies. Cabiedes J, Cabral AR, Alarcón-Segovia D. J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989 [Abstract] [Full Text] [Related]
20. Longitudinal study of antinuclear and anticardiolipin antibodies in pregnant women with systemic lupus erythematosus and antiphospholipid syndrome. Salazar-Páramo M, Jara LJ, Ramos A, Barile L, Machado G, García-De La Torre I. Rheumatol Int; 2002 Aug; 22(4):142-7. PubMed ID: 12172952 [Abstract] [Full Text] [Related] Page: [Next] [New Search]